Financials

News Discussions Technicals Forecast Seasonals

389650 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to NEXTBIOMEDICAL CO., LTD. operating, investing, and financing activities

389650 free cash flow for Q1 25 is 70.09 M KRW. For 2024, 389650 free cash flow was -1.64 B KRW and operating cash flow was -1.2 B KRW.

Q3 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q3 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—